|
|
GADOLINIUM 6,6,7,7,8,8,8-HEPTAFLUORO-2,2-DIMETHYL-3,5-OCTANEDIONATE |
GADOLINIUM 6,6,7,7,8,8,8-HEPTAFLUORO-2,2-DIMETHYL-3,5-OCTANEDIONATE |
|
|
GADOTERIDOL RELATED COMPOUND A 10-(2-HYDROXYPROPYL)-1,4,7,10-TETRAAZACYCLODEDODECANE-1,4,7-TRIAACETIC ACID USP(CRM STANDARD) |
GADOTERIDOL RELATED COMPOUND A 10-(2-HYDROXYPROPYL)-1,4,7,10-TETRAAZACYCLODEDODECANE-1,4,7-TRIAACETIC ACID USP(CRM STANDARD) |
|
|
GADOTERIDOL RELATED COMPOUND B1,4,7,10-TETRAAZACYCLODODECANE-1,4,7-TRIACETIC ACID, MONOGADOLINIUM SALT USP(CRM STANDARD) |
GADOTERIDOL RELATED COMPOUND B1,4,7,10-TETRAAZACYCLODODECANE-1,4,7-TRIACETIC ACID, MONOGADOLINIUM SALT USP(CRM STANDARD) |
|
|
Gadoversetamide Related Compound A (200 mg) (Hydrogen[8,11,14-tris(carboxymethyl)-6-oxo-2-oxa-5,8,11,14-tetraazahexadecan-16-oato(4-)]gadolinium) |
Gadoversetamide Related Compound A (200 mg) (Hydrogen[8,11,14-tris(carboxymethyl)-6-oxo-2-oxa-5,8,11,14-tetraazahexadecan-16-oato(4-)]gadolinium) |
|
|
GADOVERSETAMIDE RELATED COMPOUND AHYDROGEN[8,11,14-TRIS(CARBOXYMETHYL)-6-OXO-2-OXA-5,8,11,14-TETRAAZAHEXADECAN-16-OATO(4-)]GADOLINIUM USP(CRM STANDARD) |
GADOVERSETAMIDE RELATED COMPOUND AHYDROGEN[8,11,14-TRIS(CARBOXYMETHYL)-6-OXO-2-OXA-5,8,11,14-TETRAAZAHEXADECAN-16-OATO(4-)]GADOLINIUM USP(CRM STANDARD) |
|
|
|